
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
05/15/2025 | Q1 | -- | $2.3M | -$1.65 | -- | -- |
03/31/2025 | Q4 | -- | $3M | -$1.35 | -- | -- |
11/14/2024 | Q3 | -- | $2.5M | -$1.35 | -- | -- |
08/14/2024 | Q2 | -- | $2.3M | -$1.80 | -- | -- |
05/20/2024 | Q1 | -- | $3.6M | -$1.20 | -- | -- |
12/31/2023 | Q4 | -- | $4.2M | $1.65 | -- | -- |
11/14/2023 | Q3 | -- | $4.9M | -$0.90 | -- | -- |
06/30/2023 | Q2 | -- | $5.5M | -$0.60 | -- | -- |
05/15/2023 | Q1 | -- | $4.2M | -$0.45 | -- | -- |
03/08/2023 | Q4 | -- | $4M | $14.55 | -- | -- |
11/14/2022 | Q3 | -- | $6.3M | -$0.75 | -- | -- |
06/30/2022 | Q2 | -- | $7.4M | -$0.15 | -- | -- |
03/31/2022 | Q1 | -- | $7.5M | -$1.20 | -- | -- |
12/31/2021 | Q4 | -- | $7.2M | -$1.50 | -- | -- |
11/12/2021 | Q3 | -- | $7M | -$1.65 | -- | -- |
08/10/2021 | Q2 | -- | $7.7M | -$1.20 | -- | -- |
05/13/2021 | Q1 | -- | $7M | -$1.35 | -- | -- |
12/31/2020 | Q4 | -- | $8.6M | $4.35 | -- | -- |
11/16/2020 | Q3 | -- | $8.4M | -$1.05 | -- | -- |
08/13/2020 | Q2 | -- | $6.4M | -$1.80 | -- | -- |
03/31/2020 | Q1 | -- | $5.7M | -$1.65 | -- | -- |
03/30/2020 | Q4 | -- | $6.3M | -$1.80 | -- | -- |
11/14/2019 | Q3 | -- | $6M | -$1.80 | -- | -- |
08/14/2019 | Q2 | -- | $6.4M | -$1.95 | -- | -- |
04/16/2019 | Q1 | -- | $6.3M | -$2.10 | -- | -- |
12/31/2018 | Q4 | -- | $7.2M | -$3.45 | -- | -- |
11/13/2018 | Q3 | -- | $6.7M | -$18.30 | -- | -- |
08/09/2018 | Q2 | $11M | $7M | -$3.90 | $0.30 | -$4.20 |
04/02/2018 | Q1 | $12.5M | $7.3M | -$3.30 | $1.05 | -$4.35 |
12/31/2017 | Q4 | $10.8M | $9.3M | -$6.45 | $0.83 | -$7.28 |
11/08/2017 | Q3 | $11.5M | $10.6M | -$16.35 | $0.90 | -$17.25 |
08/09/2017 | Q2 | $12.4M | $10.3M | -$1.35 | $1.20 | -$2.55 |
05/09/2017 | Q1 | $13.1M | $11.7M | -$0.75 | $2.63 | -$3.38 |
03/14/2017 | Q4 | $13M | $10.7M | -$1.80 | $2.63 | -$4.43 |
11/08/2016 | Q3 | $13.8M | $12.9M | $1.95 | $3.23 | -$1.28 |
08/04/2016 | Q2 | -- | $12M | $1.50 | -- | -- |
05/05/2016 | Q1 | -- | $13M | $2.10 | -- | -- |
03/10/2016 | Q4 | -- | $14.3M | $2.40 | -- | -- |
11/19/2015 | Q3 | -- | $15.9M | $3.75 | -- | -- |
ClearOne reported $2.3M worth of top line sales in its most recent quarter.
ClearOne announced earnings per share of -$1.65 which represents a miss of analyst forecast a -- per share.
ClearOne reported $121K that represents $0.07 per share over the last quarter.
ClearOne's earnings are forecast to grow from -$5.55 per share to -- per share next year representing an increase of --.
ClearOne's next earnings date is August 14, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.